SeLux rakes in $25 mln Series B
Massachusetts-based-based SeLux Diagnostics, a developer of a next generation phenotyping platform, has raised $25 million in Series B financing, according to a source familiar with the transaction. Sands Capital Ventures led the round with participation from RA Capital Management, Schooner Capital and Northpond Ventures.
12 December 2018•1 min read
